The present invention relates to compounds with the formula (I), or a
pharmaceutically acceptable salt thereof: 1
The invention also relates to pharmaceutical compositions comprising the
compounds of formula (I) or formula (II) and methods of treating a
condition that is mediated by the modulation of 11-.beta.-hsd-1, the
method comprising administering to a mammal an effective amount of a
compound of formula (I) or formula (II).
